These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 26863534)

  • 21. Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients.
    Falagas ME; Rafailidis PI; Ioannidou E; Alexiou VG; Matthaiou DK; Karageorgopoulos DE; Kapaskelis A; Nikita D; Michalopoulos A
    Int J Antimicrob Agents; 2010 Feb; 35(2):194-9. PubMed ID: 20006471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Shedding light on the use of colistin: still gaps to be filled].
    Luque S; Grau S; Berenguer N; Horcajada JP; Sorlí L; Montero MM; Salas E
    Enferm Infecc Microbiol Clin; 2011 Apr; 29(4):287-96. PubMed ID: 21440335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous colistin sulfate: a rarely used form of polymyxin E for the treatment of severe multidrug-resistant Gram-negative bacterial infections.
    Huang J; Tang YQ; Sun JY
    Scand J Infect Dis; 2010 Apr; 42(4):260-5. PubMed ID: 20085424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New colistin population pharmacokinetic data in critically ill patients suggesting an alternative loading dose rationale.
    Grégoire N; Mimoz O; Mégarbane B; Comets E; Chatelier D; Lasocki S; Gauzit R; Balayn D; Gobin P; Marchand S; Couet W
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7324-30. PubMed ID: 25267662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colistin Use in Patients with Extreme Renal Function: From Dialysis to Augmented Clearance.
    Aitullina A; Krūmiņa A; Svirskis Š; Purviņa S
    Medicina (Kaunas); 2019 Jan; 55(2):. PubMed ID: 30709064
    [No Abstract]   [Full Text] [Related]  

  • 26. Colistin-associated Acute Kidney Injury in Severely Ill Patients: A Step Toward a Better Renal Care? A Prospective Cohort Study.
    Dalfino L; Puntillo F; Ondok MJ; Mosca A; Monno R; Coppolecchia S; Spada ML; Bruno F; Brienza N
    Clin Infect Dis; 2015 Dec; 61(12):1771-7. PubMed ID: 26354965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics and risk factors of colistin-induced nephrotoxicity.
    Kim J; Lee KH; Yoo S; Pai H
    Int J Antimicrob Agents; 2009 Nov; 34(5):434-8. PubMed ID: 19726164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parenteral colistin for the treatment of severe infections: a single center experience.
    Tanita MT; Carrilho CM; Garcia JP; Festti J; Cardoso LT; Grion CM
    Rev Bras Ter Intensiva; 2013; 25(4):297-305. PubMed ID: 24553511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Renal Toxicity of Colistin Therapy With Neutrophil Gelatinase-associated Lipocalin: a Biomarker of Renal Tubular Damage.
    Ordooei Javan A; Salamzadeh J; Shokouhi S; Sahraei Z
    Iran J Kidney Dis; 2017 Nov; 11(6):447-455. PubMed ID: 29190605
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Greater optimisation of pharmacokinetic/pharmacodynamic parameters through a loading dose of intravenous colistin in paediatric patients.
    Wacharachaisurapol N; Phasomsap C; Sukkummee W; Phaisal W; Chanakul A; Wittayalertpanya S; Chariyavilaskul P; Puthanakit T
    Int J Antimicrob Agents; 2020 Jun; 55(6):105940. PubMed ID: 32179149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colistin treatment in carbapenem-resistant Acinetobacter baumannii pneumonia patients: Incidence of nephrotoxicity and outcomes.
    Kwon KH; Oh JY; Yoon YS; Jeong YJ; Kim KS; Shin SJ; Chung JW; Huh HJ; Chae SL; Park SY
    Int J Antimicrob Agents; 2015 Jun; 45(6):605-9. PubMed ID: 25772644
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical assessment of colistin in treating infections caused by multidrug-resistant gram-negative bacillus in patients with severe burn].
    Zhang JP; Yang XS; Chen J; Peng YZ; Huang YS
    Zhonghua Shao Shang Za Zhi; 2009 Oct; 25(5):372-6. PubMed ID: 19951562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome analysis of colistin-treated burn center patients.
    Wilkinson RE; Hill DM; Hickerson WL
    Burns; 2017 Sep; 43(6):1244-1249. PubMed ID: 28410932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.
    Markou N; Markantonis SL; Dimitrakis E; Panidis D; Boutzouka E; Karatzas S; Rafailidis P; Apostolakos H; Baltopoulos G
    Clin Ther; 2008 Jan; 30(1):143-51. PubMed ID: 18343250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association between colistin dose and microbiologic outcomes in patients with multidrug-resistant gram-negative bacteremia.
    Vicari G; Bauer SR; Neuner EA; Lam SW
    Clin Infect Dis; 2013 Feb; 56(3):398-404. PubMed ID: 23090926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic.
    Michalopoulos AS; Tsiodras S; Rellos K; Mentzelopoulos S; Falagas ME
    Clin Microbiol Infect; 2005 Feb; 11(2):115-21. PubMed ID: 15679485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous renal replacement therapy-related strategies to avoid colistin toxicity: a clinically orientated review.
    Honoré PM; Jacobs R; Joannes-Boyau O; Lochy S; Boer W; De Waele E; Van Gorp V; De Regt J; Collin V; Spapen HD
    Blood Purif; 2014; 37(4):291-5. PubMed ID: 25096804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ten years with colistin: a retrospective case series.
    Katz DE; Marchaim D; Assous MV; Yinnon A; Wiener-Well Y; Ben-Chetrit E
    Int J Clin Pract; 2016 Sep; 70(9):706-11. PubMed ID: 27291693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness and safety of colistin: prospective comparative cohort study.
    Paul M; Bishara J; Levcovich A; Chowers M; Goldberg E; Singer P; Lev S; Leon P; Raskin M; Yahav D; Leibovici L
    J Antimicrob Chemother; 2010 May; 65(5):1019-27. PubMed ID: 20299494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between colistin dose and development of nephrotoxicity.
    Lee YJ; Wi YM; Kwon YJ; Kim SR; Chang SH; Cho S
    Crit Care Med; 2015 Jun; 43(6):1187-93. PubMed ID: 25756417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.